Literature DB >> 11576521

Impaired glucose tolerance as a disease.

A D Baron1.   

Abstract

Current criteria for diagnosing diabetes, based on fasting plasma glucose levels during administration of the oral glucose tolerance test (OGTT), are poorly sensitive and are only modestly predictive of microvascular risk. The period after administration of OGTT is far more predictive and more closely resembles the postprandial state where microvascular risk is elevated. However, persons who do not yet exhibit symptoms of diabetes may nonetheless have impaired glucose tolerance or dysglycemia, whereby macrovascular disease can develop at a glucose level lower than the threshold for microvascular disease and can progress in a graded fashion. This article reviews the factors that may cause dysglycemia (including insulin resistance and obesity) and how diet, blood pressure control, and the use of statins or glycemic/insulin sensitizing may reduce cardiovascular risk in this prediabetic population.

Entities:  

Mesh:

Year:  2001        PMID: 11576521     DOI: 10.1016/s0002-9149(01)01832-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity.

Authors:  Shi-Bing Yang; Hye Young Lee; David Matthew Young; An-Chi Tien; Ashley Rowson-Baldwin; Yu Yu Shu; Yuh Nung Jan; Lily Yeh Jan
Journal:  J Mol Med (Berl)       Date:  2011-11-22       Impact factor: 4.599

2.  Metabolic syndrome and obesity in an insect.

Authors:  Rudolf J Schilder; James H Marden
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-28       Impact factor: 11.205

3.  HCV synergizes with body weight in the promotion of insulin resistance.

Authors:  A Delgado-Borrego; Y Kamegaya; S H Jordan; S Agrawal; C Valim; R T Chung
Journal:  J Viral Hepat       Date:  2011-02       Impact factor: 3.728

4.  Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance.

Authors:  Aymin Delgado-Borrego; Yun-Sheen Liu; Sergio H Jordan; Saurabh Agrawal; Hui Zhang; Marielle Christofi; Deborah Casson; A Benedict Cosimi; Raymond T Chung
Journal:  Liver Transpl       Date:  2008-02       Impact factor: 5.799

Review 5.  Exercise therapy in type 2 diabetes.

Authors:  Stephan F E Praet; Luc J C van Loon
Journal:  Acta Diabetol       Date:  2009-05-29       Impact factor: 4.280

6.  Serum leptin and its relation to anthropometric measures of obesity in pre-diabetic Saudis.

Authors:  Nasser M Al-Daghri; Omar S Al-Attas; Khalid Al-Rubeaan; Mehad Mohieldin; Mohammad Al-Katari; Alan F Jones; Sudhesh Kumar
Journal:  Cardiovasc Diabetol       Date:  2007-07-07       Impact factor: 9.951

7.  The impact of probiotics' administration on glycemic control, body composition, gut microbiome, mitochondria, and other hormonal signals in adolescents with prediabetes - A randomized, controlled trial study protocol.

Authors:  Charikleia Stefanaki; Flora Bacopoulou; Athanasios Michos
Journal:  Contemp Clin Trials Commun       Date:  2018-06-02

8.  Predicting glucose intolerance with normal fasting plasma glucose by the components of the metabolic syndrome.

Authors:  Dee Pei; Jiunn-Diann Lin; Du-An Wu; Chang-Hsun Hsieh; Yi-Jen Hung; Shi-Wen Kuo; Ko-Lin Kuo; Chung-Ze Wu; Jer-Chuan Li
Journal:  Ann Saudi Med       Date:  2007 Sep-Oct       Impact factor: 1.526

9.  Feasibility of procedures for a randomised pilot study of reduced exertion, high-intensity interval training (REHIT) with non-diabetic hyperglycaemia patients.

Authors:  Matthew Haines
Journal:  Pilot Feasibility Stud       Date:  2020-02-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.